Genmab is committed to improving the lives of patients with cancer and other serious diseases by creating and developing innovative and differentiated antibody therapeutics. 

In addition to advancing the medical and scientific knowledge of Genmab products, the purpose of the investigator sponsored trial program is to provide investigator support for external clinical research in disease areas that help discover new opportunities to address unmet medical needs.